Lean Body Mass During GLP-1-Based Therapy and the Potential Role of Dietary Protein: Evidence From Energy-Restriction Trials.

Vlachogiannakou PA, Tentolouris A, Kokkinos A, Liberopoulos E, Stefanou MI, Tentolouris N

Open source

DOI
10.1111/dom.71540
Published
2026 Nov 8
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71540,
  title = {Lean Body Mass During GLP-1-Based Therapy and the Potential Role of Dietary Protein: Evidence From Energy-Restriction Trials.},
  author = {Vlachogiannakou PA and Tentolouris A and Kokkinos A and Liberopoulos E and Stefanou MI and Tentolouris N},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.71540},
  url = {https://doi.org/10.1111/dom.71540}
}

RIS

TY  - JOUR
TI  - Lean Body Mass During GLP-1-Based Therapy and the Potential Role of Dietary Protein: Evidence From Energy-Restriction Trials.
AU  - Vlachogiannakou PA
AU  - Tentolouris A
AU  - Kokkinos A
AU  - Liberopoulos E
AU  - Stefanou MI
AU  - Tentolouris N
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.71540
UR  - https://doi.org/10.1111/dom.71540
ER  - 

APA

PA, V., A, T., A, K., E, L., MI, S., & N, T. (2026). Lean Body Mass During GLP-1-Based Therapy and the Potential Role of Dietary Protein: Evidence From Energy-Restriction Trials.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71540

Source records